Retention of HIV-infected Children on antiretroviral treatment in HIV care and treatment programs in Kenya, mozambique, rwanda, and tanzania

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 3, 2013, Pages

  McNairy, Margaret L ^a,b   Lamb, Matthew R ^a   Carter, Rosalind J ^a   Fayorsey, Ruby ^a   Tene, Gilbert ^a   Mutabazi, Vincent ^c   Gusmao, Eduarda ^a   Panya, Millembe ^a   Sheriff, Mushin ^a   Abrams, Elaine J ^a,d  

^a Department of Medicine   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c RWANDA BIOMEDICAL CENTER   (Rwanda)

^d NONE   (United States)

Author keywords

Antiretrovirals; HIV; Pediatric; Retention

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; KENYA; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RWANDA; SCHOOL CHILD; SURVIVAL; TANZANIA;

EID: 85027944806     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318278bcb0     Document Type: Article

References (54)

1. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland; 2010. Available at: http://www.unaids.org/globalreport/ global-report.htm.
2. WHO, UNAIDS, UNICEF. Global HIV/AIDS Response, Epidemic Update and Health Sector Progress Towards Universal Access, Progress Report 2011. Geneva, Switzerland; 2011. Available at: http://www.who.int/hiv/pub/progress-report2011/ en/index.html.
3. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:1915-1927.
4. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
5. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med 2011;8:e1001044.
6. Desmonde S, Coffie P, Aka E, et al. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Cote d'Ivoire, 2004-2009. BMC Infect Dis. 2011;11:182.
7. Rouet F, Fassinou P, Inwoley A, et al. Long-term survival and immunovirological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS. 2006;20:2315-2319.
8. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS. 2004;18:1905-1913.
9. O'Brien DP, Sauvageot D, Olson D, et al. Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis. 2007;44:1245-1248.
10. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359:2233-2244.
11. KIDS-ART-LINC. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
12. Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Cote d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88:490-499.
13. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899.
14. Davies MA, Keiser O, Technau K, et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
15. Sauvageot D, Schaefer M, Olson D, et al. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children, 5 years of age. Pediatrics. 2010;125:e1039-e1047.
16. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127:e423-e441.
17. Ekouevi DK, Azondekon A, Dicko F, et al. 12-month mortality and lossto- program in antiretroviral-treated children: the IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health. 2011;11:519.
18. Fenner L, Brinkhof MW, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524-532.
19. Ellis J, Molyneux EM. Experience of anti-retroviral treatment for HIVinfected children in Malawi: the 1st 12 months. Ann Trop Paediatr. 2007;27:261-267.
20. Mugavero MJ, Amico KR, Westfall AO, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59:86-93.
21. ICAP, Columbia University. Available at: http://www.columbia-icap.org/ Accessed June 1, 2012.
22. Lahuerta M, Lima J, Elul B, et al. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011;58:e75-e86.
23. WHO. Antiretroviral Therapy for HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access. Geneva, Switzerland; 2006. Available at: http://www.who.int/hiv/pub/guidelines/WHOpaediatric.pdf.
24. WHO. Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access, Revision 2010. Geneva, Switzerland; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599801-eng.pdf.
25. WHO. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. Geneva, Switzerland; 2008.
26. Vaz P, Macassa E, Santos P, et al. National Guideline on Treatment for HIV-Infected Children, Mozambique. Maputo, Mozambique; 2008.
27. The United Republic of Tanzania MoHaSW-NACP. National Guideline for the Management of HIV and AIDS, Third Edition. Dar es Salaam, Tanzania; 2008.
28. National AIDS/STI Control Program K. Guidelines for Antiretroviral Therapy in Kenya, 4th edn. Nairobi, Kenya: Ministry of Medical Services; 2011.
29. Vaz P, Macassa E, Santos P, et al. National Guideline on Treatment for HIV-Infected Children, Mozambique. Maputo, Mozambique; 2011.
30. The United Republic of Tanzania MoHaSW-NACP. National Guideline for the Management of HIV and AIDS, Fourth Edition. Dar es Salam, Tanzania; 2012.
31. Chi BH, Yiannoutsos CT, Westfall AO, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med 2011;8:e1001111.
32. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000:1-27.
33. McGuire M, Munyenyembe T, Szumilin E, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15(Suppl 1):55-62.
34. Braitstein P, Katshcke A, Shen C, et al. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health. 2010;15:833-841.
35. Asfawesen GY, Solomie J, Bisirat T, et al. Outcome in a paediatric cohort receiving ART in Addis Abeba, Ethiopia. Acta Paediatr. 2011; 100:1164-1167.
36. Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33.
37. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
38. Fetzer BC, Hosseinipour MC, Kamthuzi P, et al. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi. Trop Med Int Health. 2009;14:862-869.
39. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-1810.
40. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
41. Chatterjee A, Tripathi S, Gass R, et al. Implementing services for Early Infant Diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries. BMC Public Health. 2011;11:553.
42. UNAIDS website. Available at: http://www.unaids.org/en/regionscountries/ countries. Accessed April 1, 2012.
43. Lowrance DW, Ndamage F, Kayirangwa E, et al. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005. J Acquir Immune Defic Syndr. 2009;52: 49-55.
44. Franke MF, Stulac SN, Rugira IH, et al. High human immunodeficiency virus-free survival of infants born to human immunodeficiency viruspositive mothers in an integrated program to decrease child mortality in rural Rwanda. Pediatr Infect Dis J. 2011;30:614-616.
45. van Griensven J, De Naeyer L, Uwera J, et al. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/- nurse-based care. BMC Pediatr. 2008;8:39.
46. Rich ML, Miller AC, Niyigena P, et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012;59:e35-e42.
47. Fatti G, Grimwood A, Mothibi E, et al. The effect of patient load on antiretroviral treatment programmatic outcomes at primary health care facilities in South Africa: a multicohort study. J Acquir Immune Defic Syndr. 2011;58:e17-e19.
48. Lambdin BH, Micek MA, Koepsell TD, et al. Patient volume, human resource levels, and attrition from HIV Treatment programs in central Mozambique. J Acquir Immune Defic Syndr. 2011;57:e33-e39.
49. Thomson KA, Cheti EO, Reid T. Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya. Trans R Soc Trop Med Hyg. 2011;105:320-326.
50. Tweya H, Gareta D, Chagwera F, et al. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the 'Back-to-Care' project in Lilongwe, Malawi. Trop Med Int Health. 2010;15(Suppl 1):82-89.
51. Nash D, Wu Y, Elul B, et al. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries. AIDS. 2011;25:1523-1533.
52. Nyandiko WM, Otieno-Nyunya B, Musick B, et al. Outcomes of HIVexposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting. J Acquir Immune Defic Syndr. 2010;54:42-50.
53. Ioannidis JP, Taha TE, Kumwenda N, et al. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Int J Epidemiol. 1999;28:769-775.
54. van Kooten Niekerk NK, Knies MM, Howard J, et al. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr. 2006;52:3-11.